obstructive sleep apnea news

FDA, obstructive sleep apnea and Zepbound

FDA approves first medication for obstructive sleep apnea, which also promotes weight loss

The FDA approved a new drug treatment for obstructive sleep apnea that improves the condition through weight loss. Sleep expert Dr. Wendy Troxel discusses the impact of the new development.

People on MSN · 14h

Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as tirzepatide, to help people treat obstructive sleep apnea.

McKnight's Long-Term Care News · 1h

FDA approves Zepbound for sleep apnea in patients with obesity

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

CNN on MSN · 5d

FDA approves weight-loss drug Zepbound for obstructive sleep apnea

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.

The New York Times · 5d

F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.

ABC · 5d

FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.

Medscape · 1d

Obesity Drug Zepbound Approved for Obstructive Sleep Apnea

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to severe OSA in people with obesity.

Yahoo · 3d

FDA approves Zepbound for obstructive sleep apnea

ConsumerAffairs · 3d

FDA approves Zepbound as a treatment for obstructive sleep apnea

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and Drug Administration has appro

Boise State Public Radio · 3d

FDA approves weight loss drug Zepbound to treat obstructive sleep apnea

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

Milwaukee Journal Sentinel5d

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication approved ...

MedCity News3d

Eli Lilly’s Zepbound Becomes First FDA-Approved Drug Therapy for Sleep Apnea

The FDA late Friday approved Lilly’s tirzepatide, brand name Zepbound, for the treatment of moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity. The product’s prescribing ...